The WEBAPPAC web-application
ADRs, breast cancer
EVENT, BREAST CANCER
Based on all these encouraging results of mobile health in patients monitoring, we proposed to implement a dedicated web-application for patients initiating adjuvant hormone therapy for breast cancer and to assess its benefits, notably on medication adherence and quality of life. The WEBAPPAC web-application has been developed as a “companion software”, which allows to provide information and advices to patients through different supports (short video, diagram, text …) and to share with health staff, in her environment, symptoms, ADRs, after-effects and patient’s experience.The WEBAPPAC web-application (compatible with Smartphone or tablet (Android or Apple system) or computer) allows patients to declare the occurrence of symptoms or side-effects and to immediately obtain an adapted and graduated response by the health staff (Fig. 
A graduated immediate response adapted to the patient through the WEBAPPAC web-applicationBesides this personalized monitoring, the web-application is intended to improve the management of ADRs induced by hormone therapy, by:
Providing health and dietary advices (physical activities and sports, practical advice, “take care of yourself” advice cards, cooking recipes, etc.)Providing information that will allow patients to apply symptomatic treatments without a prescription in close collaboration with their pharmacist (lubricant, level 1 analgesic, etc.)Referring patients to primary health care professionals (attending physician), organizations and structures adapted to their needs (sports educators, social workers, dieticians, patient associations, etc.).Alerting the nurse accompanying the patient on the breast cancer treatment pathway in the event of non-adherence with the hormone therapy treatment.However, it is to notice that this device should not be considered as an emergency alert.In this context, we implemented the WEBAPPAC study, herein presented. To our knowledge, this randomized study is the first one, to date, aiming to evaluate the effectiveness of using a web-application on adherence to adjuvant hormone therapy among breast cancer patients with breast cancer.